ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceutical Buffers Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-30M7068
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Buffers Market Insights Forecast to 2028
BUY CHAPTERS

Global Biopharmaceutical Buffers Market Research Report 2025

Code: QYRE-Auto-30M7068
Report
August 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA

Biopharmaceutical Buffers Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical Buffers Market

Biopharmaceutical Buffers Market

The global market for Biopharmaceutical Buffers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Buffers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Buffers.
The Biopharmaceutical Buffers market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical Buffers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Buffers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biopharmaceutical Buffers Market Report

Report Metric Details
Report Name Biopharmaceutical Buffers Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals, Lonza, Becton, and Dickinson and Company, GEA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biopharmaceutical Buffers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biopharmaceutical Buffers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Biopharmaceutical Buffers Market report?

Ans: The main players in the Biopharmaceutical Buffers Market are GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals, Lonza, Becton, and Dickinson and Company, GEA

What are the Application segmentation covered in the Biopharmaceutical Buffers Market report?

Ans: The Applications covered in the Biopharmaceutical Buffers Market report are Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other

What are the Type segmentation covered in the Biopharmaceutical Buffers Market report?

Ans: The Types covered in the Biopharmaceutical Buffers Market report are Sterile Buffer, Non-sterile Buffer

Recommended Reports

Biopharma Equipment

Drug Components

Biopharma Services

1 Biopharmaceutical Buffers Market Overview
1.1 Product Definition
1.2 Biopharmaceutical Buffers by Type
1.2.1 Global Biopharmaceutical Buffers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sterile Buffer
1.2.3 Non-sterile Buffer
1.3 Biopharmaceutical Buffers by Application
1.3.1 Global Biopharmaceutical Buffers Market Value by Application (2024 VS 2031)
1.3.2 Recombinant Proteins
1.3.3 Monoclonal Antibodies
1.3.4 Antibiotics
1.3.5 Probiotics
1.3.6 Other
1.4 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts
1.4.1 Global Biopharmaceutical Buffers Revenue 2020-2031
1.4.2 Global Biopharmaceutical Buffers Sales 2020-2031
1.4.3 Global Biopharmaceutical Buffers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biopharmaceutical Buffers Market Competition by Manufacturers
2.1 Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biopharmaceutical Buffers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biopharmaceutical Buffers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biopharmaceutical Buffers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biopharmaceutical Buffers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biopharmaceutical Buffers, Product Type & Application
2.7 Global Key Manufacturers of Biopharmaceutical Buffers, Date of Enter into This Industry
2.8 Global Biopharmaceutical Buffers Market Competitive Situation and Trends
2.8.1 Global Biopharmaceutical Buffers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biopharmaceutical Buffers Players Market Share by Revenue
2.8.3 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biopharmaceutical Buffers Market Scenario by Region
3.1 Global Biopharmaceutical Buffers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biopharmaceutical Buffers Sales by Region: 2020-2031
3.2.1 Global Biopharmaceutical Buffers Sales by Region: 2020-2025
3.2.2 Global Biopharmaceutical Buffers Sales by Region: 2026-2031
3.3 Global Biopharmaceutical Buffers Revenue by Region: 2020-2031
3.3.1 Global Biopharmaceutical Buffers Revenue by Region: 2020-2025
3.3.2 Global Biopharmaceutical Buffers Revenue by Region: 2026-2031
3.4 North America Biopharmaceutical Buffers Market Facts & Figures by Country
3.4.1 North America Biopharmaceutical Buffers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biopharmaceutical Buffers Sales by Country (2020-2031)
3.4.3 North America Biopharmaceutical Buffers Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biopharmaceutical Buffers Market Facts & Figures by Country
3.5.1 Europe Biopharmaceutical Buffers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biopharmaceutical Buffers Sales by Country (2020-2031)
3.5.3 Europe Biopharmaceutical Buffers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biopharmaceutical Buffers Market Facts & Figures by Region
3.6.1 Asia Pacific Biopharmaceutical Buffers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biopharmaceutical Buffers Sales by Region (2020-2031)
3.6.3 Asia Pacific Biopharmaceutical Buffers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biopharmaceutical Buffers Market Facts & Figures by Country
3.7.1 Latin America Biopharmaceutical Buffers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biopharmaceutical Buffers Sales by Country (2020-2031)
3.7.3 Latin America Biopharmaceutical Buffers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biopharmaceutical Buffers Market Facts & Figures by Country
3.8.1 Middle East and Africa Biopharmaceutical Buffers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biopharmaceutical Buffers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biopharmaceutical Buffers Sales by Type (2020-2031)
4.1.1 Global Biopharmaceutical Buffers Sales by Type (2020-2025)
4.1.2 Global Biopharmaceutical Buffers Sales by Type (2026-2031)
4.1.3 Global Biopharmaceutical Buffers Sales Market Share by Type (2020-2031)
4.2 Global Biopharmaceutical Buffers Revenue by Type (2020-2031)
4.2.1 Global Biopharmaceutical Buffers Revenue by Type (2020-2025)
4.2.2 Global Biopharmaceutical Buffers Revenue by Type (2026-2031)
4.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Type (2020-2031)
4.3 Global Biopharmaceutical Buffers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biopharmaceutical Buffers Sales by Application (2020-2031)
5.1.1 Global Biopharmaceutical Buffers Sales by Application (2020-2025)
5.1.2 Global Biopharmaceutical Buffers Sales by Application (2026-2031)
5.1.3 Global Biopharmaceutical Buffers Sales Market Share by Application (2020-2031)
5.2 Global Biopharmaceutical Buffers Revenue by Application (2020-2031)
5.2.1 Global Biopharmaceutical Buffers Revenue by Application (2020-2025)
5.2.2 Global Biopharmaceutical Buffers Revenue by Application (2026-2031)
5.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Application (2020-2031)
5.3 Global Biopharmaceutical Buffers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Biopharmaceutical Buffers Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Danaher Corporation
6.3.1 Danaher Corporation Company Information
6.3.2 Danaher Corporation Description and Business Overview
6.3.3 Danaher Corporation Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Danaher Corporation Biopharmaceutical Buffers Product Portfolio
6.3.5 Danaher Corporation Recent Developments/Updates
6.4 Sartorius StedimBiotech
6.4.1 Sartorius StedimBiotech Company Information
6.4.2 Sartorius StedimBiotech Description and Business Overview
6.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Product Portfolio
6.4.5 Sartorius StedimBiotech Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Biopharmaceutical Buffers Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Eppendorf
6.6.1 Eppendorf Company Information
6.6.2 Eppendorf Description and Business Overview
6.6.3 Eppendorf Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eppendorf Biopharmaceutical Buffers Product Portfolio
6.6.5 Eppendorf Recent Developments/Updates
6.7 Roche
6.7.1 Roche Company Information
6.7.2 Roche Description and Business Overview
6.7.3 Roche Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Roche Biopharmaceutical Buffers Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Nova Biomedicals
6.8.1 Nova Biomedicals Company Information
6.8.2 Nova Biomedicals Description and Business Overview
6.8.3 Nova Biomedicals Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nova Biomedicals Biopharmaceutical Buffers Product Portfolio
6.8.5 Nova Biomedicals Recent Developments/Updates
6.9 Lonza
6.9.1 Lonza Company Information
6.9.2 Lonza Description and Business Overview
6.9.3 Lonza Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lonza Biopharmaceutical Buffers Product Portfolio
6.9.5 Lonza Recent Developments/Updates
6.10 Becton, and Dickinson and Company
6.10.1 Becton, and Dickinson and Company Company Information
6.10.2 Becton, and Dickinson and Company Description and Business Overview
6.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Product Portfolio
6.10.5 Becton, and Dickinson and Company Recent Developments/Updates
6.11 GEA
6.11.1 GEA Company Information
6.11.2 GEA Description and Business Overview
6.11.3 GEA Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GEA Biopharmaceutical Buffers Product Portfolio
6.11.5 GEA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biopharmaceutical Buffers Industry Chain Analysis
7.2 Biopharmaceutical Buffers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biopharmaceutical Buffers Production Mode & Process Analysis
7.4 Biopharmaceutical Buffers Sales and Marketing
7.4.1 Biopharmaceutical Buffers Sales Channels
7.4.2 Biopharmaceutical Buffers Distributors
7.5 Biopharmaceutical Buffers Customer Analysis
8 Biopharmaceutical Buffers Market Dynamics
8.1 Biopharmaceutical Buffers Industry Trends
8.2 Biopharmaceutical Buffers Market Drivers
8.3 Biopharmaceutical Buffers Market Challenges
8.4 Biopharmaceutical Buffers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA
List of Tables
 Table 1. Global Biopharmaceutical Buffers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biopharmaceutical Buffers Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biopharmaceutical Buffers Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biopharmaceutical Buffers Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biopharmaceutical Buffers Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biopharmaceutical Buffers Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biopharmaceutical Buffers Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biopharmaceutical Buffers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biopharmaceutical Buffers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biopharmaceutical Buffers, Product Type & Application
 Table 12. Global Key Manufacturers of Biopharmaceutical Buffers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biopharmaceutical Buffers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Buffers as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biopharmaceutical Buffers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biopharmaceutical Buffers Sales by Region (2020-2025) & (K MT)
 Table 18. Global Biopharmaceutical Buffers Sales Market Share by Region (2020-2025)
 Table 19. Global Biopharmaceutical Buffers Sales by Region (2026-2031) & (K MT)
 Table 20. Global Biopharmaceutical Buffers Sales Market Share by Region (2026-2031)
 Table 21. Global Biopharmaceutical Buffers Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biopharmaceutical Buffers Revenue Market Share by Region (2020-2025)
 Table 23. Global Biopharmaceutical Buffers Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biopharmaceutical Buffers Revenue Market Share by Region (2026-2031)
 Table 25. North America Biopharmaceutical Buffers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biopharmaceutical Buffers Sales by Country (2020-2025) & (K MT)
 Table 27. North America Biopharmaceutical Buffers Sales by Country (2026-2031) & (K MT)
 Table 28. North America Biopharmaceutical Buffers Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biopharmaceutical Buffers Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biopharmaceutical Buffers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biopharmaceutical Buffers Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Biopharmaceutical Buffers Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Biopharmaceutical Buffers Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biopharmaceutical Buffers Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biopharmaceutical Buffers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biopharmaceutical Buffers Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Biopharmaceutical Buffers Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biopharmaceutical Buffers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biopharmaceutical Buffers Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Biopharmaceutical Buffers Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Biopharmaceutical Buffers Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biopharmaceutical Buffers Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biopharmaceutical Buffers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biopharmaceutical Buffers Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Biopharmaceutical Buffers Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biopharmaceutical Buffers Sales (K MT) by Type (2020-2025)
 Table 51. Global Biopharmaceutical Buffers Sales (K MT) by Type (2026-2031)
 Table 52. Global Biopharmaceutical Buffers Sales Market Share by Type (2020-2025)
 Table 53. Global Biopharmaceutical Buffers Sales Market Share by Type (2026-2031)
 Table 54. Global Biopharmaceutical Buffers Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biopharmaceutical Buffers Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biopharmaceutical Buffers Revenue Market Share by Type (2020-2025)
 Table 57. Global Biopharmaceutical Buffers Revenue Market Share by Type (2026-2031)
 Table 58. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2020-2025)
 Table 59. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2026-2031)
 Table 60. Global Biopharmaceutical Buffers Sales (K MT) by Application (2020-2025)
 Table 61. Global Biopharmaceutical Buffers Sales (K MT) by Application (2026-2031)
 Table 62. Global Biopharmaceutical Buffers Sales Market Share by Application (2020-2025)
 Table 63. Global Biopharmaceutical Buffers Sales Market Share by Application (2026-2031)
 Table 64. Global Biopharmaceutical Buffers Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biopharmaceutical Buffers Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biopharmaceutical Buffers Revenue Market Share by Application (2020-2025)
 Table 67. Global Biopharmaceutical Buffers Revenue Market Share by Application (2026-2031)
 Table 68. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2020-2025)
 Table 69. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2026-2031)
 Table 70. GE Healthcare Company Information
 Table 71. GE Healthcare Description and Business Overview
 Table 72. GE Healthcare Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. GE Healthcare Biopharmaceutical Buffers Product
 Table 74. GE Healthcare Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Thermo Fisher Scientific Biopharmaceutical Buffers Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Danaher Corporation Company Information
 Table 81. Danaher Corporation Description and Business Overview
 Table 82. Danaher Corporation Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Danaher Corporation Biopharmaceutical Buffers Product
 Table 84. Danaher Corporation Recent Developments/Updates
 Table 85. Sartorius StedimBiotech Company Information
 Table 86. Sartorius StedimBiotech Description and Business Overview
 Table 87. Sartorius StedimBiotech Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Sartorius StedimBiotech Biopharmaceutical Buffers Product
 Table 89. Sartorius StedimBiotech Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Merck Biopharmaceutical Buffers Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Eppendorf Company Information
 Table 96. Eppendorf Description and Business Overview
 Table 97. Eppendorf Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Eppendorf Biopharmaceutical Buffers Product
 Table 99. Eppendorf Recent Developments/Updates
 Table 100. Roche Company Information
 Table 101. Roche Description and Business Overview
 Table 102. Roche Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Roche Biopharmaceutical Buffers Product
 Table 104. Roche Recent Developments/Updates
 Table 105. Nova Biomedicals Company Information
 Table 106. Nova Biomedicals Description and Business Overview
 Table 107. Nova Biomedicals Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Nova Biomedicals Biopharmaceutical Buffers Product
 Table 109. Nova Biomedicals Recent Developments/Updates
 Table 110. Lonza Company Information
 Table 111. Lonza Description and Business Overview
 Table 112. Lonza Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Lonza Biopharmaceutical Buffers Product
 Table 114. Lonza Recent Developments/Updates
 Table 115. Becton, and Dickinson and Company Company Information
 Table 116. Becton, and Dickinson and Company Description and Business Overview
 Table 117. Becton, and Dickinson and Company Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Becton, and Dickinson and Company Biopharmaceutical Buffers Product
 Table 119. Becton, and Dickinson and Company Recent Developments/Updates
 Table 120. GEA Company Information
 Table 121. GEA Description and Business Overview
 Table 122. GEA Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. GEA Biopharmaceutical Buffers Product
 Table 124. GEA Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Biopharmaceutical Buffers Distributors List
 Table 128. Biopharmaceutical Buffers Customers List
 Table 129. Biopharmaceutical Buffers Market Trends
 Table 130. Biopharmaceutical Buffers Market Drivers
 Table 131. Biopharmaceutical Buffers Market Challenges
 Table 132. Biopharmaceutical Buffers Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biopharmaceutical Buffers
 Figure 2. Global Biopharmaceutical Buffers Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biopharmaceutical Buffers Market Share by Type: 2024 & 2031
 Figure 4. Sterile Buffer Product Picture
 Figure 5. Non-sterile Buffer Product Picture
 Figure 6. Global Biopharmaceutical Buffers Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biopharmaceutical Buffers Market Share by Application: 2024 & 2031
 Figure 8. Recombinant Proteins
 Figure 9. Monoclonal Antibodies
 Figure 10. Antibiotics
 Figure 11. Probiotics
 Figure 12. Other
 Figure 13. Global Biopharmaceutical Buffers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Biopharmaceutical Buffers Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Biopharmaceutical Buffers Sales (2020-2031) & (K MT)
 Figure 16. Global Biopharmaceutical Buffers Average Price (USD/MT) & (2020-2031)
 Figure 17. Biopharmaceutical Buffers Report Years Considered
 Figure 18. Biopharmaceutical Buffers Sales Share by Manufacturers in 2024
 Figure 19. Global Biopharmaceutical Buffers Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Biopharmaceutical Buffers Players: Market Share by Revenue in Biopharmaceutical Buffers in 2024
 Figure 21. Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Biopharmaceutical Buffers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Biopharmaceutical Buffers Sales Market Share by Country (2020-2031)
 Figure 24. North America Biopharmaceutical Buffers Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Biopharmaceutical Buffers Sales Market Share by Country (2020-2031)
 Figure 28. Europe Biopharmaceutical Buffers Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Biopharmaceutical Buffers Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Biopharmaceutical Buffers Revenue Market Share by Region (2020-2031)
 Figure 36. China Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Biopharmaceutical Buffers Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Biopharmaceutical Buffers Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Biopharmaceutical Buffers Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Biopharmaceutical Buffers Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Biopharmaceutical Buffers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Biopharmaceutical Buffers by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Biopharmaceutical Buffers by Type (2020-2031)
 Figure 58. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Biopharmaceutical Buffers by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Biopharmaceutical Buffers by Application (2020-2031)
 Figure 61. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2020-2031)
 Figure 62. Biopharmaceutical Buffers Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Biopharmaceutical Fermenters Market Insights Forecast to 2030
Global Biopharmaceutical Culture Media Market Insights Forecast to 2030
Global Cell Culture Buffers Market Research Report 2024
Global Biopharmaceutical Excipients Market Insights Forecast to 2030
Global Blocking Buffer Market Research Report 2025
Global Cell Culture Media and Buffers Market Research Report 2024
Global Cancer Biopharmaceuticals Market Insights Forecast to 2030
Biopharmaceutical Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceuticals Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologic Medical Product Market Research Report 2025
Global Flow Cytometry Buffer Market Research Report 2025
Biopharmaceutical Excipient Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non oncology Biopharmaceuticals Market Insights Forecast to 2030
Biopharmaceutical Glass Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specialty Biopharmaceutical Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biologic Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical Processing Consumables Market Research Report 2024
Global Cell Buffer Solutions Market Research Report 2025
Global Bio Similars Subsequent Entry Biologic Market Research Report 2024
Global Biopharmaceuticals Manufacturing Consumables Testing Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions